Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.

Pirodavir (R77975) is a capsid-binding, antipicornaviral agent with in vitro activity against most rhinovirus (RV) serotypes. We conducted four double-blind, controlled trials to assess the efficacy of intranasal pirodavir in experimentally induced RV infection of susceptible volunteers. Intranasal...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hayden, F G, Andries, K, Janssen, P A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189373/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1503435/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.727
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!